IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 84 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 2.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,834,000 | -39.3% | 2,555,909 | +3.6% | 0.00% | 0.0% |
| Q3 2016 | $6,317,000 | +89.5% | 2,467,717 | +13.3% | 0.00% | 0.0% |
| Q2 2016 | $3,334,000 | -22.8% | 2,178,892 | -0.1% | 0.00% | 0.0% |
| Q1 2016 | $4,320,000 | -36.4% | 2,181,897 | -0.7% | 0.00% | 0.0% |
| Q4 2015 | $6,791,000 | -5.6% | 2,197,647 | +2.3% | 0.00% | 0.0% |
| Q3 2015 | $7,197,000 | +4.6% | 2,148,240 | +15.8% | 0.00% | 0.0% |
| Q2 2015 | $6,881,000 | -4.5% | 1,854,713 | -4.5% | 0.00% | 0.0% |
| Q1 2015 | $7,207,000 | +81.7% | 1,942,504 | +115.9% | 0.00% | 0.0% |
| Q4 2014 | $3,967,000 | +214.3% | 899,600 | +63.3% | 0.00% | – |
| Q3 2014 | $1,262,000 | -21.9% | 550,898 | -1.1% | 0.00% | – |
| Q2 2014 | $1,615,000 | +991.2% | 557,001 | +1431.5% | 0.00% | – |
| Q1 2014 | $148,000 | – | 36,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,550,000 | $16,437,000 | 2.17% |
| Ghost Tree Capital, LLC | 550,000 | $2,547,000 | 1.57% |
| HealthCor Management, L.P. | 3,350,000 | $15,511,000 | 0.94% |
| EAM Investors, LLC | 541,969 | $2,509,000 | 0.45% |
| Baker Brothers Advisors | 3,171,765 | $14,685,000 | 0.21% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 405,729 | $1,878,000 | 0.16% |
| Spark Investment Management LLC | 169,000 | $779,000 | 0.14% |
| CARL DOMINO INC | 50,137 | $232,000 | 0.13% |
| NATIXIS | 3,149,816 | $14,583,000 | 0.12% |
| HOLLENCREST CAPITAL MANAGEMENT | 132,000 | $611,000 | 0.10% |